| 1 | gonadal mesoderm development (GO:0007506) | 7.39107828 |
| 2 | positive regulation of protein kinase C signaling (GO:0090037) | 7.19012426 |
| 3 | response to parathyroid hormone (GO:0071107) | 6.17214005 |
| 4 | melanin biosynthetic process (GO:0042438) | 5.68060012 |
| 5 | uterus development (GO:0060065) | 5.45438660 |
| 6 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 5.39531082 |
| 7 | melanin metabolic process (GO:0006582) | 5.09674248 |
| 8 | secondary metabolite biosynthetic process (GO:0044550) | 5.00737429 |
| 9 | positive regulation of cellular amine metabolic process (GO:0033240) | 4.86863789 |
| 10 | complement activation, alternative pathway (GO:0006957) | 4.58416128 |
| 11 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 4.46446857 |
| 12 | seminiferous tubule development (GO:0072520) | 4.40650782 |
| 13 | regulation of triglyceride catabolic process (GO:0010896) | 4.39700754 |
| 14 | cellular response to ATP (GO:0071318) | 4.11797217 |
| 15 | anatomical structure regression (GO:0060033) | 4.11512601 |
| 16 | L-phenylalanine metabolic process (GO:0006558) | 4.09290417 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.09290417 |
| 18 | negative regulation of metanephros development (GO:0072217) | 4.02328973 |
| 19 | atrioventricular valve morphogenesis (GO:0003181) | 3.92792509 |
| 20 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 3.88950187 |
| 21 | negative regulation of cell size (GO:0045792) | 3.82272308 |
| 22 | response to acidic pH (GO:0010447) | 3.76125083 |
| 23 | negative regulation of kidney development (GO:0090185) | 3.75924148 |
| 24 | sex determination (GO:0007530) | 3.75648893 |
| 25 | epithelial cell fate commitment (GO:0072148) | 3.74568147 |
| 26 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.70864797 |
| 27 | cardiac right ventricle morphogenesis (GO:0003215) | 3.69268252 |
| 28 | labyrinthine layer development (GO:0060711) | 3.65750510 |
| 29 | L-phenylalanine catabolic process (GO:0006559) | 3.64160361 |
| 30 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.64160361 |
| 31 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.62048135 |
| 32 | negative regulation of macrophage differentiation (GO:0045650) | 3.59839833 |
| 33 | sex differentiation (GO:0007548) | 3.59448932 |
| 34 | regulation of protein activation cascade (GO:2000257) | 3.55222547 |
| 35 | ear development (GO:0043583) | 3.54885223 |
| 36 | proline metabolic process (GO:0006560) | 3.54683412 |
| 37 | semaphorin-plexin signaling pathway (GO:0071526) | 3.53624093 |
| 38 | regulation of complement activation (GO:0030449) | 3.53215896 |
| 39 | regulation of protein kinase C signaling (GO:0090036) | 3.49778192 |
| 40 | proline biosynthetic process (GO:0006561) | 3.49066374 |
| 41 | regulation of gonadotropin secretion (GO:0032276) | 3.47088923 |
| 42 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.46961289 |
| 43 | endothelial cell morphogenesis (GO:0001886) | 3.45364573 |
| 44 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.43127736 |
| 45 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.43127736 |
| 46 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.40830412 |
| 47 | regulation of bile acid biosynthetic process (GO:0070857) | 3.39985055 |
| 48 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.33264190 |
| 49 | positive regulation of synapse maturation (GO:0090129) | 3.31932179 |
| 50 | hindbrain development (GO:0030902) | 3.25049403 |
| 51 | positive regulation of receptor recycling (GO:0001921) | 3.24107851 |
| 52 | regulation of synapse maturation (GO:0090128) | 3.23702032 |
| 53 | cell-cell junction maintenance (GO:0045217) | 3.17993768 |
| 54 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.14382366 |
| 55 | positive regulation of male gonad development (GO:2000020) | 3.12681343 |
| 56 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.11839152 |
| 57 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 3.08861390 |
| 58 | Golgi transport vesicle coating (GO:0048200) | 3.04546465 |
| 59 | COPI coating of Golgi vesicle (GO:0048205) | 3.04546465 |
| 60 | positive regulation of hormone metabolic process (GO:0032352) | 2.99896678 |
| 61 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.99658263 |
| 62 | flavonoid metabolic process (GO:0009812) | 2.98262688 |
| 63 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.95923709 |
| 64 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.94714307 |
| 65 | heart valve morphogenesis (GO:0003179) | 2.91542924 |
| 66 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.90815434 |
| 67 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.90815434 |
| 68 | regulation of triglyceride metabolic process (GO:0090207) | 2.90643049 |
| 69 | male sex determination (GO:0030238) | 2.87909871 |
| 70 | basement membrane organization (GO:0071711) | 2.86249675 |
| 71 | interferon-gamma secretion (GO:0072643) | 2.85525338 |
| 72 | mesenchymal to epithelial transition (GO:0060231) | 2.84926850 |
| 73 | regulation of ARF GTPase activity (GO:0032312) | 2.84233041 |
| 74 | regulation of cholesterol metabolic process (GO:0090181) | 2.83084104 |
| 75 | histone H4-K12 acetylation (GO:0043983) | 2.82982612 |
| 76 | regulation of cholesterol esterification (GO:0010872) | 2.78900553 |
| 77 | response to food (GO:0032094) | 2.78375751 |
| 78 | SMAD protein signal transduction (GO:0060395) | 2.77371076 |
| 79 | positive regulation of lipid catabolic process (GO:0050996) | 2.77216712 |
| 80 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.76485512 |
| 81 | exogenous drug catabolic process (GO:0042738) | 2.75339751 |
| 82 | phospholipid efflux (GO:0033700) | 2.75064697 |
| 83 | cellular response to gonadotropin stimulus (GO:0071371) | 2.72790107 |
| 84 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.72059480 |
| 85 | embryonic camera-type eye development (GO:0031076) | 2.71060884 |
| 86 | urogenital system development (GO:0001655) | 2.71044249 |
| 87 | aromatic amino acid family catabolic process (GO:0009074) | 2.70327257 |
| 88 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.69233890 |
| 89 | desmosome organization (GO:0002934) | 2.68803896 |
| 90 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.67265349 |
| 91 | positive regulation of establishment of protein localization to plasma membrane (GO:0090004) | 2.67206132 |
| 92 | facial nerve structural organization (GO:0021612) | 2.66981371 |
| 93 | regulation of plasminogen activation (GO:0010755) | 2.66920031 |
| 94 | glucose 6-phosphate metabolic process (GO:0051156) | 2.65891975 |
| 95 | phenol-containing compound biosynthetic process (GO:0046189) | 2.63707165 |
| 96 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.63431388 |
| 97 | drug catabolic process (GO:0042737) | 2.61441732 |
| 98 | response to water (GO:0009415) | 2.60401375 |
| 99 | regulation of receptor recycling (GO:0001919) | 2.59258217 |
| 100 | polarized epithelial cell differentiation (GO:0030859) | 2.59141497 |
TPSP2 
